PRODUCT

CJC-1295 + GHRP-2 (10 mg Blend)

No short description available.

Quickstart Highlights

CJC-1295 is a long-acting GHRH analog that can elevate GH levels 2–10× baseline for approximately 6 days and increase IGF-1 by 1.5–3× for 9–11 days[1]. GHRP-2 is a ghrelin-mimetic secretagogue with a plasma half-life of ~30 minutes that triggers rapid GH pulses peaking within ~25 minutes of administration[3]. Combining these peptides leverages GHRP-2’s acute pulsatile release with CJC-1295’s sustained action. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration (1 unit ≈ 33.3 mcg).
Typical daily range: 100–300 mcg once daily (gradual titration).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F) for long-term; after reconstitution, refrigerate and use within 2–4 weeks.

Reconstitution

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

Goal:Support enhanced GH pulsatility and sustained IGF-1 elevation over a defined research period[1].
Schedule:Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range:100–300 mcg daily (total blend) with gradual titration.
Reconstitution:3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
Storage:Lyophilized refrigerated or frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosage Protocols

Start:100–150 mcg daily for Weeks 1–2 to allow acclimatization[2].
Target:250–300 mcg daily by Weeks 3–12.
Frequency:Once per day (subcutaneous), preferably evening/bedtime.
Cycle Length:8–12 weeks; optional extension to 16 weeks.
Timing:Inject on an empty stomach; rotate injection sites.

Storage Instructions

Lyophilized:Refrigerate at 2–8 °C (35.6–46.4 °F); freeze at −20 °C (−4 °F) for long-term storage exceeding several months.
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks for optimal potency.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each injection; dispose in a sharps container[7].
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly on an empty stomach; GHRP-2’s GH response may be blunted by elevated blood glucose[4].
Document daily dose and site rotation to maintain consistency.
No post-cycle therapy is required; GH and IGF-1 levels return to baseline after cessation[1].

How It Works

CJC-1295 is a tetrasubstituted GHRH(1–29) analog engineered for extended half-life (~6–8 days) via protection from enzymatic degradation and reversible albumin binding[1]. A single dose can sustain elevated GH for approximately 6 days and IGF-1 elevation for 9–11 days. GHRP-2 is a synthetic hexapeptide ghrelin-mimetic that binds the GH secretagogue receptor (GHS-R1a), triggering acute GH pulses that peak within ~25 minutes[3]. Combining CJC-1295’s sustained GHRH signaling with GHRP-2’s rapid secretagogue action produces synergistic GH release that exceeds either peptide alone[6].

Lifestyle Factors

Pair with a balanced, protein-forward diet tailored to energy and recovery needs.
Combine resistance training and aerobic activity to complement GH-mediated anabolic and metabolic effects.
Prioritize quality sleep; nocturnal GH secretion is enhanced by adequate rest.
Inject on an empty stomach or after fasting for 2–3 hours; carbohydrate-rich meals may attenuate GHRP-2’s GH response[4].

Injection Technique

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[7].
Do not aspirate for subcutaneous injections; inject slowly and steadily[8].
Rotate sites systematically (abdomen, thighs, upper arms) to avoid local tissue changes[11].
Withdraw the needle at the same angle; dispose immediately in a sharps container.

Benefits and Side Effects

Benefits

Sustained elevation of GH and IGF-1 levels over extended periods with once-daily or even less frequent dosing[1].
GHRP-2 may transiently increase appetite due to ghrelin-like activity[4].
Mild, transient elevations in ACTH, cortisol, and prolactin may occur shortly after injection but remain within physiological ranges[5].
CJC-1295 at higher doses may cause transient vasodilatory effects such as facial flushing or brief lightheadedness[1].

Side Effects

Long-term pediatric studies (8 months) reported no significant adverse effects or toxicities from GHRP-2 therapy[2].
Occasional mild injection-site reactions (redness, itching) may occur with subcutaneous administration.

CJC-1295 + GHRP-2 (10 mg Blend)

Resources

Categories

Company